Chao Ma

6PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 18, 2024
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

Jonathan A Nowak, Tyler Twombly, Chao Ma

|Jun 08, 2023
Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance).

Qiao-Li Wang, Chao Ma, Chen Yuan

|Nov 11, 2022
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702.

Seohyuk Lee, Chao Ma, Qian Shi

|Aug 09, 2022
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

Justin C Brown, Chao Ma, Qian Shi

|Apr 12, 2022
Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.

Jeffrey A Meyerhardt, Hong Yue, Radosław P Nowak

|Jan 07, 2022
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).

En Cheng, Fang-Shu Ou, Chao Ma

Pageof 1